Varicella Vaccine Composition, Dosage, and Administration
Information for Healthcare Providers
Two vaccines containing varicella virus are licensed for use in the United States.
- Varivax® is the single-antigen varicella vaccine.
- ProQuad® is a combination measles, mumps, rubella, and varicella (MMRV) vaccine.
Both vaccines contain live, attenuated varicella-zoster virus derived from the Oka strain.
Children 12 months through 12 years old
- 2 doses (0.5 ml each) of varicella vaccine should be given subcutaneously, separated by at least 3 months
- MMRV vaccine is approved for healthy children in this age group
Single-antigen vaccine and MMRV vaccine can be used for the routine 2-dose varicella vaccination.
- First dose: 12 through 15 months
- Second dose: 4 through 6 years.
For the first dose, CDC recommends that MMR and varicella vaccines be given separately in children 12 through 15 months old unless the parent or caregiver expresses a preference for MMRV vaccine.
Both vaccines may be given at the same time as other vaccines for children 12 through 15 months and 4 through 6 years old.
People 13 years or older
- 2 doses (0.5 ml each) of the single-antigen varicella vaccine subcutaneously 4 to 8 weeks apart
- MMRV vaccine is not approved for people in this age group
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.